Sabuwar zoben PrEP yana rage kamuwa da cutar HIV da kaso 50%

Labarai

Sabuwar Alurar rigakafin HIV da Microbicide Advocacy Society (NHVMAS), ta ce zoben Pre-Exposure Prophylaxis (PrEP), wanda kuma aka sani da zoben dapivirine, na iya rage kamuwa da cutar kanjamau a cikin mata da kashi 50 cikin 100 idan an bi shi sosai.

PrEP miyagun ƙwayoyi ne da ke cikin haɗarin Cutar (HIV) don hana kamuwa da cutar daga yin jima’i ko amfani da miyagun ƙwayoyi.

Babban Darakta, NHVMAS, Misis Florita Durueke, ta bayyana haka a wani horon da ake yi wa ‘yan jarida mata a Legas.

Ta ce duk da cewa cutar kanjamau ta kasa tana da kashi 1.4 cikin 100, amma nauyin mata ya fi yawa.

Durueke ya ce wadanda ke tsakanin shekaru 15 zuwa 49 suna da damar rayuwa da kwayar cutar sau biyu idan aka kwatanta da takwarorinsu maza.

“Bayanai sun nuna cewa cutar kanjamau ita ce mafi girma a tsakanin mata masu shekaru 35 zuwa 39 a kashi 3.3 cikin 100 kuma mafi girma a tsakanin maza masu shekaru 50 zuwa 54 da kashi 2.3 bisa dari.

“Yawancin mata matasa shine kashi 1.3 cikin 100 amma ga samari masu shekaru daya, yawansu ya kai kashi 0.4 bisa dari,” in ji ta.

Durueke ta ce idan aka ba su ikon yin zabin da ya dace wajen amfani da PrEP, sakamakon zai bambanta ga mata.

A cewar www.hiv.gov, duk wanda ke yin jima’i kuma ba shi da kwayar cutar HIV zai iya amfani da PrEP.

PrEP yana da matukar tasiri wajen hana HIV idan an sha kamar yadda aka nuna, yana rage haɗarin watsawa daga jima’i da kusan kashi 99 cikin ɗari.

Durueke ya ce kamar tsarin iyali, akwai kayan aikin rigakafin cutar kanjamau daban-daban da tuni a kasuwa kuma ya kamata mata su yi la’akari da salon rayuwarsu yayin da suke zabar.

Ta ce zoben dapivirine na iya rage yawan kamuwa da cutar kanjamau a tsakanin mata da kashi 50 cikin 100 idan aka yi amfani da su sosai.

Ta bayyana zobe na PrEP a matsayin zoben farji mai sassauƙa, wanda aka yi da silicone wanda sannu a hankali ke fitar da maganin Antiretroviral (ARV) mai suna dapivirine tsawon wata ɗaya don rage haɗarin kamuwa da cutar kanjamau.

“A yayin binciken budaddiyar alamar, zobe na iya kare kariya daga cutar kanjamau kamar kashi 50 cikin 100.

“Zben PrEP yana ba da tsayayyen sakin dapivirine sama da wata ɗaya ba tare da buƙatar kulawa ba.

“Ƙarancin kulawa yana nufin ƙarancin nauyi a kan mai amfani don tunawa da allurai kuma yana iya ƙarfafa yin amfani da daidaito,” in ji ta.

Durueke ya ce, zoben dapivirine, wanda hadin gwiwar International Partnership for Microbicides (IPM) ta samar kuma Hukumar Lafiya ta Duniya (WHO) ta amince da shi har tsawon shekaru 18 zuwa sama, abu ne mai sauki, dadewa, mai zaman kansa kuma ba shi da lafiya.

Mata za su iya saka ko cire zoben PrEP ba tare da taimakon ma’aikacin lafiya ba.

Yana da sauƙin motsawa tare da kuma baya haifar da rashin jin daɗi ga namiji ko mace yayin jima’i. (NAN)